WANT A PROFILE LIKE THIS?
Create my FREE Plan Or learn about other options
Ranjit Vijayan
PeerJ Editor & Author
200 Points

Contributions by role

Author 100
Editor 100

Contributions by subject area

Bioinformatics
Computational Biology
COVID-19
Gastroenterology and Hepatology
Immunology
Oncology
Medical Genetics

Ranjit Vijayan

PeerJ Editor & Author

Summary

Dr. Ranjit Vijayan obtained his PhD in Life Sciences Interface/Biochemistry from the University of Oxford, UK, and his DipGrad in Management from the London School of Economics & Political Science, University of London, UK. In 2004 Dr Vijayan obtained his MSc in Computer Science from the University of Wales, Aberystwyth, UK, and prior to this his BEng in Electrical & Electronic Engineering, Nanyang Technological University, Singapore.

Dr. Vijayan's research interests include; molecular dynamics simulations of biological macromolecules, protein structure modeling, structure based drug discovery, genomics & transcriptomics, pharmacogenomics and high-performance computing.

Biochemistry Bioinformatics Biomolecules Biophysics Computational Biology Food Science & Technology Genetics Genomics Medical Genetics Omics Technologies Pharmacology

Editorial Board Member

PeerJ - the Journal of Life & Environmental Sciences
PeerJ Computer Science

Past or current institution affiliations

United Arab Emirates University

Work details

Associate Professor

United Arab Emirates University
August 2011
Biology
Associate Professor of Computational Biology/Bioinformatics

Postdoctoral Research Associate

University of Oxford
January 2009 - July 2011
Biochemistry
Postdoctoral Research Associate

Websites

  • Google Scholar
  • UAEU Institutional Webpage

PeerJ Contributions

  • Articles 1
  • Edited 1
July 5, 2022
Dynamics of the interaction between the receptor-binding domain of SARS-CoV-2 Omicron (B.1.1.529) variant and human angiotensin-converting enzyme 2
Priya Antony, Amie Jobe, Ranjit Vijayan
https://doi.org/10.7717/peerj.13680 PubMed 35811809

Academic Editor on

December 15, 2021
ANXA9 as a novel prognostic biomarker associated with immune infiltrates in gastric cancer
Tongtong Zhang, Suyang Yu, Shipeng Zhao
https://doi.org/10.7717/peerj.12605 PubMed 35003923